Back to results

Baylor University.

Plant-produced, trans-encapsidated, replicative viral nanoparticles as a vaccine platform.

Abstract

dc:description.abstract

Replicative virus-based vaccines provide potential solutions to avoid the natural deficits of traditional single-protein subunit vaccines. Unlike subunit vaccines, the infectious nature of viral particles can stimulate the innate immune response, which allows enhanced and elongated stimulation of antibody and T cell adaptive immunity. When these replicative vaccines are engineered to express antigen genes naturally in the patient's cells, cell mediated immunity is stimulated via the class I antigen presentation pathway, followed by a robust CD8+ T cell activation and interferon production. In this study, I aim to develop a safe, effective and cost-efficient transencapsidated replicative vaccine platform by encapsidating within strongly immunogenic tobacco mosaic virus (TMV) nanoparticles the self-replicative RNA of Flock House virus (FHV), an insect virus that also replicates in human and plant cells. By inserting the unique packaging signal of TMV into FHV RNA, the capsid of TMV assembles around the heterologous RNA, when TMV coat protein and FHV RNA are expressed in the same cell. First, the replication of different viral delivery vectors in both mammalian cells and plant cells was investigated and their cellular co-infection was demonstrated. The resulting successfully packaged chimeric nanoparticle improved antibody production over the standards after vaccination in mice. Next I detailed the specifics and techniques required to produce and purify these nanoparticle vaccines in planta via agroinoculation. To further explore the possibility of increasing the yield of plant-produced nanoparticle vaccines, an optimized spray-on inoculation method was developed using a low-toxicity surfactant to aid agro-inoculation. Unexpectedly, this also decreased contaminating plant pathogenesis-related proteins. A continuing study is also discussed on trans-locating FHV replication to endoplasmic reticulum, which suggests potential to further increase plant yield of nanoparticle vaccines as well.

Degree

thesis:*
Name thesis:degree_name
Ph.D.
Level thesis:degree_level
Doctoral
Grantor
Baylor University.
Year dc:date.issued
2016

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Zhou, Yiyang, 1988-
Advisor dc:contributor.advisor
  • Kearney, Christopher Michel, 1958-

Subjects

dc:subject × 2

Rights

dc:rights
Statement dc:rights
  • Baylor University works are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. Contact libraryquestions@baylor.edu for inquiries about permission.
Language dc:language.iso
en

Identifiers

dc:identifier.*
Handle dc:identifier.uri
https://hdl.handle.net/2104/9799
OAI identifier oai:identifier
oai:baylor-ir.tdl.org:2104/9799

Chain of custody

source
Harvested from
Baylor University
Base URL
baylor-ir.tdl.org/server/oai/request
Last updated
2026-07-24
Source record
OAI-PMH GetRecord
citation

Zhou, Yiyang, 1988-. Plant-produced, trans-encapsidated, replicative viral nanoparticles as a vaccine platform.. Doctoral thesis, Baylor University., 2016. https://hdl.handle.net/2104/9799